JCR Pharmaceuticals Co., Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a JCRRF research report →
Companywww.jcrpharm.co.jp
JCR Pharmaceuticals Co. , Ltd. , a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.
- CEO
- Toru Ashida
- IPO
- 2021
- Employees
- 934
- HQ
- Ashiya, JP
Price Chart
Valuation
- Market Cap
- $508.71M
- P/E
- 28.50
- P/S
- 1.54
- P/B
- 1.32
- EV/EBITDA
- 34.13
- Div Yield
- 3.93%
Profitability
- Gross Margin
- 74.56%
- Op Margin
- 1.07%
- Net Margin
- 5.40%
- ROE
- 4.64%
- ROIC
- 0.29%
Growth & Income
- Revenue
- $40.57B · 22.68%
- Net Income
- $2.19B · 146.08%
- EPS
- $17.58 · 145.75%
- Op Income
- $433.71M
- FCF YoY
- 24.32%
Performance & Tape
- 52W High
- $5.00
- 52W Low
- $3.78
- 50D MA
- $4.17
- 200D MA
- $4.42
- Beta
- 0.17
- Avg Volume
- 559.62
Get TickerSpark's AI analysis on JCRRF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our JCRRF Coverage
We haven't published any research on JCRRF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate JCRRF Report →